About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Cancer Therapy Delivers Chemotherapy Drugs into the Spinal Cord

Font : A-A+

Highlights:
  • A novel treatment for intramedullary spinal cord tumors has been developed.
  • This treatment delivers chemotherapy drugs into the spinal cord to treat hard-to-reach spinal tumors using nanotechnology.
  • Intramedullary spinal cord tumors are a type of central nervous system tumors that result in back or neck pain, radicular pain, gait disturbance, and bowel and bladder dysfunction.

New Cancer Therapy Delivers Chemotherapy Drugs into the Spinal Cord

A new cancer therapy that uses magnetic nanoparticles to deliver chemotherapy drugs into the spinal cord to treat hard-to-reach spinal tumors has been developed by a research team at the University of Illinois at Chicago.

The unique delivery system represents a novel way to target chemotherapy drugs to spinal cancer cells, which are hard to reach because the drugs must cross the blood-brain barrier.

Advertisement


Spinal cord tumors are a challenge to treat because they are difficult to surgically remove due to their proximity to healthy spinal tissue and because chemotherapy drugs must cross the blood-brain barrier in order to reach them. Intramedullary spinal cord tumors account for 8 percent to 10 percent of all spinal cord tumors and are common among children and adolescents. Average survival for patients with these tumors is 15.5 months.

Doxorubicin, a commonly used chemotherapy to treat spinal tumors, is delivered intravenously and affects the whole body with poor penetration to the spine. Radiation therapy is also problematic for these tumors because the radiation often damages healthy nearby spinal tissue and can have devastating effects, including paraplegia.
Advertisement

"Getting chemotherapy drugs to spinal tumors has always been a problem," said Dr. Ankit Mehta, assistant professor of neurosurgery and director of spinal oncology in the UIC College of Medicine and corresponding author on the paper. "But we can precisely guide chemotherapy to cancer cells into the spinal cord using magnetic nanoparticles."

The researchers used a unique rat model with implanted human intramedullary spinal cord tumors to show that magnetic nanoparticles could successfully be used to kill tumor cells.

First, they created nanoparticles made up of tiny, metallic magnets bound to particles of doxorubicin. Next, they implanted a magnet just under the skin covering the spinal vertebrae in the rat models. Then they injected the magnetic nanoparticles into the space around the spinal cord where the tumor was located.

The magnet implanted in close proximity to the tumor guided the nanoparticles to the tumor sites. The researchers were able to show that tumor cells took up the nanoparticles and underwent apoptosis - in other words, they were effectively destroyed. The impact of the nanoparticles on nearby healthy cells was very minimal, Mehta said.

"This proof-of-concept study shows that magnetic nanoparticles are an effective way to deliver chemotherapy to an area of the body that has been difficult to reach with available treatments," he said. "We will continue to investigate the potential of this therapy and hope to enter human trials if it continues to show promise."

References :
  1. Magnetic Drug Targeting: A Novel Treatment for Intramedullary Spinal Cord Tumors - (https://www.nature.com/articles/s41598-018-29736-5)


  2. Source: Eurekalert

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chrisy Ngilneii. (2018, July 31). New Cancer Therapy Delivers Chemotherapy Drugs into the Spinal Cord. Medindia. Retrieved on May 22, 2022 from https://www.medindia.net/news/healthwatch/new-cancer-therapy-delivers-chemotherapy-drugs-into-the-spinal-cord-181451-1.htm.

  • MLA

    Chrisy Ngilneii. "New Cancer Therapy Delivers Chemotherapy Drugs into the Spinal Cord". Medindia. May 22, 2022. <https://www.medindia.net/news/healthwatch/new-cancer-therapy-delivers-chemotherapy-drugs-into-the-spinal-cord-181451-1.htm>.

  • Chicago

    Chrisy Ngilneii. "New Cancer Therapy Delivers Chemotherapy Drugs into the Spinal Cord". Medindia. https://www.medindia.net/news/healthwatch/new-cancer-therapy-delivers-chemotherapy-drugs-into-the-spinal-cord-181451-1.htm. (accessed May 22, 2022).

  • Harvard

    Chrisy Ngilneii. 2021. New Cancer Therapy Delivers Chemotherapy Drugs into the Spinal Cord. Medindia, viewed May 22, 2022, https://www.medindia.net/news/healthwatch/new-cancer-therapy-delivers-chemotherapy-drugs-into-the-spinal-cord-181451-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Prevent Hacking of Medical Devices: FDA Sounds Alarm
Black Water: Benefits and Uses
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Chemotherapy Chemotherapy Drugs Reiki and Pranic Healing Cancer Facts Cancer 

Most Popular on Medindia

Calculate Ideal Weight for Infants The Essence of Yoga Color Blindness Calculator Sanatogen Drug - Food Interactions Selfie Addiction Calculator Blood Donation - Recipients Drug Interaction Checker Indian Medical Journals Blood - Sugar Chart

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use